Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment

The Covid-19 pandemic has caused millions of deaths worldwide. Although vaccines have been developed, patients on immunosuppressive therapy are less likely to respond. This study was aimed at investigating the efficacy of a Covid-19 vaccine (Pfizer-BioNTech) in patients with non-Hodgkin lymphoma tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tvito, Ariella, Ronson, Aaron, Ghosheh, Renan, Kharit, Mira, Ashkenazi, Jakob, Magen, Sophie, Broide, Ellen, Benayoun, Emmanuel, Rowe, Jacob M., Ofran, Yishai, Ganzel, Chezi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691955/
https://www.ncbi.nlm.nih.gov/pubmed/34952139
http://dx.doi.org/10.1016/j.exphem.2021.12.396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691955/
https://www.ncbi.nlm.nih.gov/pubmed/34952139
http://dx.doi.org/10.1016/j.exphem.2021.12.396

Ejemplares similares